Glycyrrhizin treatment is associated with attenuation of lipopolysaccharide-induced acute lung injury by inhibiting cyclooxygenase-2 and inducible nitric oxide synthase expression. [electronic resource]
Producer: 20110111Description: e29-35 p. digitalISSN:- 1095-8673
- Acute Lung Injury -- metabolism
- Animals
- Cyclooxygenase 2 -- genetics
- Cyclooxygenase 2 Inhibitors -- pharmacology
- Glycyrrhizic Acid -- pharmacology
- Interleukin-1beta -- analysis
- Lipopolysaccharides -- toxicity
- Lung -- pathology
- Male
- Mice
- Mice, Inbred BALB C
- Nitric Oxide -- analysis
- Nitric Oxide Synthase Type II -- antagonists & inhibitors
- Peroxidase -- metabolism
- Tumor Necrosis Factor-alpha -- analysis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.